A detailed history of First Heartland Consultants, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, First Heartland Consultants, Inc. holds 15,860 shares of PFE stock, worth $415,690. This represents 0.05% of its overall portfolio holdings.

Number of Shares
15,860
Previous 15,411 2.91%
Holding current value
$415,690
Previous $431,000 6.5%
% of portfolio
0.05%
Previous 0.03%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$27.7 - $31.39 $12,437 - $14,094
449 Added 2.91%
15,860 $459,000
Q2 2024

Jul 25, 2024

SELL
$25.26 - $29.6 $9,472 - $11,100
-375 Reduced 2.38%
15,411 $431,000
Q1 2024

May 07, 2024

BUY
$25.89 - $29.73 $71,792 - $82,441
2,773 Added 21.31%
15,786 $438,000
Q4 2023

Feb 08, 2024

BUY
$26.13 - $33.94 $102,769 - $133,486
3,933 Added 43.31%
13,013 $375,000
Q3 2023

Nov 09, 2023

SELL
$32.09 - $37.51 $15,916 - $18,604
-496 Reduced 5.18%
9,080 $301,000
Q2 2023

Jul 26, 2023

SELL
$36.12 - $41.79 $18,529 - $21,438
-513 Reduced 5.08%
9,576 $351,000
Q1 2023

Apr 17, 2023

BUY
$39.39 - $51.28 $18,158 - $23,640
461 Added 4.79%
10,089 $411,000
Q4 2022

Jan 13, 2023

SELL
$41.75 - $54.5 $3,465 - $4,523
-83 Reduced 0.85%
9,628 $0
Q3 2022

Oct 20, 2022

SELL
$43.76 - $53.42 $76,011 - $92,790
-1,737 Reduced 15.17%
9,711 $424,000
Q2 2022

Jul 12, 2022

SELL
$46.53 - $55.17 $1,814 - $2,151
-39 Reduced 0.34%
11,448 $600,000
Q1 2022

Apr 21, 2022

SELL
$45.75 - $56.69 $10,614 - $13,152
-232 Reduced 1.98%
11,487 $594,000
Q4 2021

Feb 11, 2022

BUY
$41.32 - $61.25 $2,437 - $3,613
59 Added 0.51%
11,719 $692,000
Q3 2021

Nov 15, 2021

SELL
$39.25 - $50.42 $169,128 - $217,259
-4,309 Reduced 26.98%
11,660 $502,000
Q2 2021

Aug 16, 2021

SELL
$35.91 - $40.68 $271,192 - $307,215
-7,552 Reduced 32.11%
15,969 $625,000
Q1 2021

May 17, 2021

BUY
$33.49 - $37.77 $81,749 - $92,196
2,441 Added 11.58%
23,521 $852,000
Q4 2020

Jan 29, 2021

BUY
$33.47 - $42.56 $75,106 - $95,504
2,244 Added 11.91%
21,080 $776,000
Q3 2020

Oct 21, 2020

BUY
$31.75 - $37.25 $40,735 - $47,791
1,283 Added 7.31%
18,836 $691,000
Q2 2020

Jul 16, 2020

BUY
$30.12 - $36.54 $174,063 - $211,164
5,779 Added 49.08%
17,553 $574,000
Q1 2020

May 14, 2020

BUY
$27.03 - $38.62 $6,730 - $9,616
249 Added 2.16%
11,774 $384,000
Q4 2019

Feb 13, 2020

BUY
$32.92 - $37.36 $2,962 - $3,362
90 Added 0.79%
11,525 $452,000
Q3 2019

Nov 18, 2019

BUY
$32.49 - $42.13 $9,129 - $11,838
281 Added 2.52%
11,435 $411,000
Q2 2019

Aug 12, 2019

SELL
$36.98 - $41.52 $52,215 - $58,626
-1,412 Reduced 11.24%
11,154 $483,000
Q1 2019

May 15, 2019

BUY
$37.5 - $41.2 $4,762 - $5,232
127 Added 1.02%
12,566 $534,000
Q4 2018

Feb 12, 2019

SELL
$38.47 - $43.86 $22,428 - $25,570
-583 Reduced 4.48%
12,439 $543,000
Q3 2018

Nov 16, 2018

SELL
$34.47 - $41.81 $44,879 - $54,436
-1,302 Reduced 9.09%
13,022 $574,000
Q2 2018

Aug 09, 2018

SELL
$32.98 - $35.16 $164,207 - $175,061
-4,979 Reduced 25.79%
14,324 $520,000
Q1 2018

May 15, 2018

BUY
$31.91 - $37.02 $45,248 - $52,494
1,418 Added 7.93%
19,303 $685,000
Q4 2017

Feb 26, 2018

SELL
$33.26 - $35.29 $708,271 - $751,500
-21,295 Reduced 54.35%
17,885 $648,000
Q3 2017

Nov 15, 2017

BUY
$31.0 - $34.15 $1.21 Million - $1.34 Million
39,180
39,180 $1.4 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $147B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track First Heartland Consultants, Inc. Portfolio

Follow First Heartland Consultants, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Heartland Consultants, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Heartland Consultants, Inc. with notifications on news.